Alerts over medicines and health products have doubled over the past three years, with increasing wariness prompted by prominent litigation over breast implants.
The Medicine and Healthcare products Regulatory Agency issued 35 alerts in the past year, up from 17 three years ago.
The watchdog monitors medicines and devices to ensure their safety. It was launched in 2003 under the Department of Health and six years ago merged with the National Institute for Biological Standards and Control.
Lawyers said the rise in alerts was in part the result of better manufacturers beefing up internal processes. “It is an indication that manufacturers are improving their procedures when it comes to spotting performance issues relating to their products,” Peter Rudd-Clarke, a partner at RPC, a City of